Vycor Medical (VYCO) Cash from Financing Activities (2010 - 2026)
Vycor Medical (VYCO) reported Cash from Financing Activities of -$14910.0 for Q1 2026, up 15.72% year-over-year from -$12885.1 in Q1 2025, and little changed quarter-over-quarter from -$14874.0 in Q4 2025.
Vycor Medical (VYCO) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Vycor Medical (VYCO) has 17 years of Cash from Financing Activities data on file, last reported at -$14910.0 in Q1 2026.
- Cash from Financing Activities for Q1 2026 came in at -$14910.0, up 15.72% year-over-year; the trailing twelve-month figure through Mar 2026 was $1968.0 (up 121.25% YoY), and the FY2025 annual result was -$812.0, up 89.25% from the prior year.
- Cash from Financing Activities held at -$14910.0 in Q1 2026 per VYCO's latest filing, from -$14874.0 in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $68409.0 in Q1 2022 and troughed at -$17690.0 in Q1 2025.
- A 5-year average of $8401.4 and a median of -$8819.0 in 2023 frame the typical range for Cash from Financing Activities.
- The sharpest annual moves came in 2022 and 2023: Cash from Financing Activities surged 293.33% in 2022, then sank 130.31% in 2023.
- A 5-year view of Cash from Financing Activities shows it stood at $37497.0 in 2022, then plunged by 130.31% to -$11367.0 in 2023, then retreated by 22.06% to -$13874.0 in 2024, then decreased by 7.21% to -$14874.0 in 2025, then decreased by 0.24% to -$14910.0 in 2026.
- Business Quant data shows VYCO's Cash from Financing Activities at -$14910.0 in Q1 2026, -$14874.0 in Q4 2025, and $36957.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Vycor Medical | - | - | 375,153.00 | -14,910.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14,910.00 |
| Mar 31, 2026 | -14,910.00 |
| Dec 31, 2025 | -14,874.00 |
| Dec 31, 2025 | -14,874.00 |
| Sep 30, 2025 | 36,957.00 |
| Sep 30, 2025 | 36,957.00 |
| Jun 30, 2025 | -5,205.00 |
| Jun 30, 2025 | -5,205.00 |
| Mar 31, 2025 | -17,690.00 |
| Mar 31, 2025 | -17,690.00 |
| Dec 31, 2024 | -13,874.00 |
| Dec 31, 2024 | -13,874.00 |
| Sep 30, 2024 | 32,898.00 |
| Sep 30, 2024 | 32,898.00 |
| Jun 30, 2024 | -10,595.00 |
| Jun 30, 2024 | -10,595.00 |
| Mar 31, 2024 | -15,983.00 |
| Mar 31, 2024 | -15,983.00 |
| Dec 31, 2023 | -11,367.00 |
| Dec 31, 2023 | -11,367.00 |